Patent Number | Title | Applicant | Opposition Date |
---|---|---|---|
EP3334747 | Charged Depth Filtration Of Antigen-Binding Proteins | AMGEN INC. | Jun 26, 2024 |
EP3294325 | Enhancing The Effect Of Car-Engineered T Cells By Means Of Nucleic Acid Vaccination | BIONTECH CELL&GENE THERAPIES GMBH | Apr 25, 2024 |
EP3892295 | Individualized Vaccines For Cancer | BIONTECH SE | Jan 25, 2024 |
EP3417071 | System And Method For Targeted Depletion Of Nucleic Acids | F. HOFFMANN-LA ROCHE AG | Jan 4, 2024 |
EP3681483 | Process For Lyophilized Pharmaceutical Formulation Of A Therapeutic Protein | AMGEN INC. | Feb 20, 2023 |
EP3590949 | Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses Thereof | MODERNATX, INC. | Feb 17, 2023 |
EP3718565 | Respiratory Virus Vaccines | MODERNATX, INC. | Jan 26, 2023 |
EP2791160 | Modified Nucleoside, Nucleotide, And Nucleic Acid Compositions | MODERNA THERAPEUTICS, INC. | Dec 2, 2022 |
EP2922554 | Terminally Modified Rna | MODERNA THERAPEUTICS, INC. | Nov 23, 2022 |
EP3432935 | Site-Specific Bio-Conjugation Methods And Compositions Useful For Nanopore Systems | GENIA TECHNOLOGIES, INC. | Nov 21, 2022 |
Feel free to send us a message here and we will get back to you